Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1000 of 2529 entries
View as:

Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCC

Phase: N/A Priority: Normal
NCT ID: NCT01379521 Org: User:
Start: 06/30/11 End: 06/30/15 Due: 06/30/16

Study of the Effect of Serelaxin on High-sensitivity Cardiac Troponin I (Hs-cTnI) Release in Patients With Chronic Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT02625922 Org: User:
Start: 02/05/16 End: 01/11/17 Due: 01/11/18

Canadian Treat and Extend Analysis Trial With Ranibizumab

Phase: N/A Priority: Normal
NCT ID: NCT02103738 Org: User:
Start: 05/08/13 End: 07/31/19 Due: 07/31/20

A 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01216072 Org: User:
Start: 08/31/10 End: 08/31/12 Due: 08/31/13

Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT03891953 Org: User:
Start: 05/07/19 End: 09/30/25 Due: 09/30/26

Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00927901 Org: User:
Start: 06/30/09 End: 11/30/09 Due: 11/30/10

A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT03512197 Org: User:
Start: 07/20/18 End: 02/12/21 Due: 02/12/22

Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01813019 Org: User:
Start: 11/30/13 End: 11/30/14 Due: 11/30/15

A Crossover Study to Determine the 24 Hour Lung Function Profile of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00622635 Org: User:
Start: 01/31/08 End: 07/31/08 Due: 07/31/09

Study of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT02143622 Org: User:
Start: 03/31/15 End: 08/31/18 Due: 08/31/19

Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion

Phase: N/A Priority: Normal
NCT ID: NCT01599650 Org: User:
Start: 05/31/12 End: 05/31/15 Due: 05/31/16

Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT00412529 Org: User:
Start: 12/31/06 End: - Due: -

Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD

Phase: N/A Priority: Normal
NCT ID: NCT03954626 Org: User:
Start: 06/07/19 End: 07/31/19 Due: 07/31/20

Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis

Phase: N/A Priority: Normal
NCT ID: NCT01090310 Org: User:
Start: 08/31/10 End: 07/31/11 Due: 07/31/12

Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT05834738 Org: User:
Start: 07/20/23 End: 08/19/26 Due: 08/19/27

A Study of the Efficacy and Safety of NVA237 in Patients With Moderate to Severe COPD

Phase: N/A Priority: Normal
NCT ID: NCT02371629 Org: User:
Start: 06/24/15 End: 11/16/16 Due: 11/16/17

Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02690701 Org: User:
Start: 02/10/16 End: 02/19/18 Due: 02/19/19

Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy

Phase: N/A Priority: Normal
NCT ID: NCT04984876 Org: User:
Start: 12/07/21 End: 11/27/23 Due: 11/27/24

Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis

Phase: N/A Priority: Normal
NCT ID: NCT02565576 Org: User:
Start: 09/29/15 End: 12/19/17 Due: 12/19/18

RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe

Phase: N/A Priority: Normal
NCT ID: NCT00688623 Org: User:
Start: 06/24/09 End: 11/07/16 Due: 11/07/17

Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00088595 Org: User:
Start: 01/31/04 End: 07/31/08 Due: 07/31/09

Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients

Phase: N/A Priority: Normal
NCT ID: NCT03369704 Org: User:
Start: 12/15/17 End: 10/20/18 Due: 10/20/19

Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT01529619 Org: User:
Start: 03/31/12 End: 12/31/13 Due: 12/31/14

Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma

Phase: N/A Priority: Normal
NCT ID: NCT02343172 Org: User:
Start: 03/13/15 End: 10/16/19 Due: 10/16/20

Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia

Phase: N/A Priority: Normal
NCT ID: NCT01585272 Org: User:
Start: 08/31/12 End: 06/30/15 Due: 06/30/16